Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Etanercept is safe and may help improve hidradenitis suppurativa, but more research is needed.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

All four treatments for early rheumatoid arthritis had similar and mostly mild side effects.

Secukinumab treatment may cause HBV reactivation and hair discoloration.

Effective immunomodulatory treatments and a personalized approach are crucial for managing severe folliculitis decalvans.

Nail loss may be a side effect of the MS drug teriflunomide.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

Oral tofacitinib successfully treated total body hair loss in one patient.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

A skin rash after the AstraZeneca COVID-19 vaccine was treated successfully with medication.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Azathioprine effectively and safely treats alopecia areata.

Etanercept may not prevent alopecia areata from coming back.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Tofacitinib may help treat Lichen Planopilaris, but more research is needed.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Isotretinoin can effectively reduce symptoms of frontal fibrosing alopecia.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.